Fair Value Calculator Fair Value Calculator
EN DE

RISHILASE (RISHILASE) Fair Value & Analysis

IN · Market cap ₹1.2B

R RISHILASE RISHILASE · BSE
Price₹124.20
Fair Value₹66.33
Upside-46.6%
Quality49/100
Watch RISHILASE for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹55.13 – ₹76.29

Fair value as of: Jul 5, 2026

From 14 valuation models · updated today

Share price +4.1% over the past month.

Price vs Fair Value (12 months)

₹146.45 ₹97.95 Fair Value ₹66.33 Jul 2025 Jul 2026

12‑month range ₹97.95 – ₹146.45 · fair‑value band ₹55.13 – ₹76.29 · the ₹124.20 price screens above the ₹66.33 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

RISHILASE (RISHILASE) currently trades at ₹124.20, while our model-based Fair Value estimate is ₹66.33 — implying the stock looks roughly 46.6% overvalued today. We read business quality at 49/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, RISHILASE generated revenue of ₹1.6B at a net margin of 2.3%. Revenue grew 7.9% year over year. It earns a return on equity of 5.0%. Net debt stands at ₹186M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹55.13 (bear case) to ₹76.29 (bull case); at ₹124.20, the current price sits above that range. The share trades about 17% below its 52-week high and 38% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.6B
Revenue growth (YoY) +7.9%
Net margin 2.3%
Return on equity 5.0%
Free cash flow −₹45.5M FY2026
P/E ratio 27.0
More key figures
Operating margin 2.1%
EPS (TTM) ₹4.60
EPS growth (YoY) -68.9%
Net debt ₹186M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

RISHILASE reported revenue of ₹1.6B in FY2026 versus ₹1.1B in FY2022, a compound +9.4%/yr. Reported net income was ₹36.7M in FY2026, compounding +83.7%/yr from FY2022.

Revenue +9.4%/yr
FY22 ₹1.1B
FY23 ₹1.3B
FY24 ₹1.4B
FY25 ₹1.5B
FY26 ₹1.6B
Net income +83.7%/yr
FY22 ₹3.2M
FY23 ₹49.1M
FY24 ₹87.3M
FY25 ₹82.5M
FY26 ₹36.7M

Is RISHILASE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "RISHILASE Fair Value". https://www.fairvalue-calculator.com/stock/RISHILASE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is RISHILASE (RISHILASE) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹66.33 versus a price of ₹124.20 — about −47% (overvalued). Model-based estimate, not financial advice.
What is the fair value of RISHILASE?
Our model-based fair value for RISHILASE is ₹66.33 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹124.20.
What is the quality score of RISHILASE?
RISHILASE has a Quality Score of 49/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of RISHILASE (RISHILASE)?
RISHILASE reported trailing-twelve-month revenue of about ₹1.6B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of RISHILASE?
The net profit margin of RISHILASE is about 2.3%, meaning it keeps roughly 2.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.